COL18A1 and hepatocellular carcinoma: The result showed that the HBsAg-negative healthy individuals had 2.33-fold higher COL18A1 mRNA expression than HCC patients and CHB patients had 1.79-fold higher COL18A1 mRNA expression than HCC patients (P = 0.000026).